[{"from": "human", "value": "Design a molecule that meets the criteria outlined in the description. The molecule is the orally bioavailable monosodium salt of montelukast, a selective cysteinyl leukotriene receptor antagonist with anti-inflammatory and bronchodilating activities. Montelukast selectively and competitively blocks the cysteinyl leukotriene 1 (CysLT1) receptor, preventing binding of the inflammatory mediator leukotriene D4 (LTD4). Inhibition of LTD4 activity results in inhibition of leukotriene-mediated inflammatory events including: migration of eosinophils and neutrophils; adhesion of leukocytes to vascular endothelium, monocyte and neutrophil aggregation; increased airway edema; increased capillary permeability; and bronchoconstriction. The CysLT1 receptor is found in a number of tissues including spleen, lung, placenta, small intestine, and nasal mucosa, and in a variety of cell types including monocyte/macrophages, mast cells, eosinophils, CD34-positive hemopoietic progenitor cells, neutrophils and endothelial cells."}, {"from": "gpt", "value": "[C][C][Branch1][C][C][Branch2][Branch1][=N][C][=C][C][=C][C][=C][Ring1][=Branch1][C][C][C@H1][Branch2][Ring1][S][C][=C][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][/C][=C][/C][=N][C][=C][Branch1][#Branch2][C][=C][C][=Branch1][Ring2][=C][Ring1][=Branch1][Cl][C][=C][Ring1][O][S][C][C][Branch1][Branch1][C][C][Ring1][Ring1][C][C][=Branch1][C][=O][O-1][O].[Na+1]"}]